CCMD
STJ

Cypress Capital Management (Delaware)’s St Jude Medical STJ Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-84,411
Closed -$6.77M – 119
2016
Q4 		$6.77M Sell
84,411
-20,200
-19% -$1.6M 1.78% 31
2016
Q3 		$8.34M Sell
104,611
-2,400
-2% -$194K 2.67% 14
2016
Q2 		$8.35M Sell
107,011
-1,142
-1% -$81.4K 2.81% 11
2016
Q1 		$5.95M Buy
108,153
+14,117
+15% +$769K 2.02% 24
2015
Q4 		$5.81M Buy
94,036
+3,675
+4% +$232K 1.74% 28
2015
Q3 		$5.7M Buy
90,361
+2,900
+3% +$207K 1.81% 29
2015
Q2 		$6.39M Sell
87,461
-225
-0.3% -$16.3K 1.83% 30
2015
Q1 		$5.74M Sell
87,686
-98,200
-53% -$6.53M 1.73% 29
2014
Q4 		$12.1M Sell
185,886
-500
-0.3% -$32.2K 3.49% 10
2014
Q3 		$11.2M Buy
186,386
+1,275
+0.7% +$83.3K 3.51% 14
2014
Q2 		$12.8M Sell
185,111
-1,165
-0.6% -$75.5K 3.85% 9
2014
Q1 		$12.2M Buy
186,276
+11,675
+7% +$760K 3.81% 12
2013
Q4 		$10.8M Sell
174,601
-1,409
-0.8% -$81.6K 3.17% 15
2013
Q3 		$9.44M Buy
176,010
+3,725
+2% +$192K 3.02% 16
2013
Q2 		$7.86M Buy
+172,285
New +$7.47M 2.74% 21

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Cypress Capital Management (Delaware)'s STJ Position: Q1 2017 in Review

Cypress Capital Management (Delaware) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 84,411 shares — an estimated $6.77M sold.

Cypress Capital Management (Delaware) first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $12.8M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Cypress Capital Management (Delaware) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Cypress Capital Management (Delaware) sold 84,411 St Jude Medical shares in Q1 2017, an estimated $6.77M.
  • Cypress Capital Management (Delaware) first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Cypress Capital Management (Delaware)'s St Jude Medical position peaked at $12.8M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q1 2017, filed 2 May 2017.